Journal for ImmunoTherapy of Cancer (Nov 2020)
287 Safety and antitumor activity of indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors
- Yi Liu,
- Capucine Baldini,
- Jameel Muzaffar,
- David Hong,
- Olivier Rixe,
- Christophe Massard,
- Timothy Yap,
- Solmaz Sahebjam,
- Ursa Brown-Glaberman,
- Andreea Varga,
- Sergey Efuni,
- Barbara Kapelan,
- Eniola Ogunmefun,
- Tomonori Tayama,
- Henry Zhao,
- Denis Healy,
- Robert Latek,
- Daisuke Nakashima,
- Emrullah Yilmaz
Affiliations
- Yi Liu
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Capucine Baldini
- 5Institut de Cancérologie Gustave Roussy, Villejuif, France
- Jameel Muzaffar
- 1H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
- David Hong
- 1MD Anderson Cancer Center, Houston, TX, USA
- Olivier Rixe
- 3Quantum Santa Fe, Albuquerque, NM, USA
- Christophe Massard
- 5Institut de Cancérologie Gustave Roussy, Villejuif, France
- Timothy Yap
- 2University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA
- Solmaz Sahebjam
- 1H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
- Ursa Brown-Glaberman
- 4University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA
- Andreea Varga
- 5Institut de Cancérologie Gustave Roussy, Villejuif, France
- Sergey Efuni
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Barbara Kapelan
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Eniola Ogunmefun
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Tomonori Tayama
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Henry Zhao
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Denis Healy
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Robert Latek
- 6Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA
- Daisuke Nakashima
- 7Kyowa Kirin Co. Ltd., Tokyo, Japan
- Emrullah Yilmaz
- 8University of New Mexico Comprehensive Comprehensive Cancer Center, Albuquerque, NM, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0287
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.